whatshot

NNCSF   $2.95  -18.06% Market Closed

NANOSONICS LTD ORD
show_chart Advanced Chart of NNCSF
Last Events:

2021-03-31 Trend pattern changed from сужающийся канал to расширяющийся канал.

2021-03-31 Signal in Stochastic changed from bullish recovery to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.

2021-03-31 Signal in MACD changed from bullish to bearish reversal. Oscillator MACD is in the positive territory it crossed the signal line from the top and falls. These factors mean that the market confirms the end of the upward trend. Last signal: main and signal line crossing.

2021-03-31 Signal in RSI changed from bullish recovery to bearish. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2021-03-31 Trend Power changed from strong to .

Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 8
Target Price Mean 3
Mean unverified/preliminary 3 / 3
Target Price Low / High 2 / 4
Median / STD DEV 3 / 0.81
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy - -
rsi ActivelyBuy - -
macd - - -
stoch Buy - -
ma20 - - -
ma50 - - -
ma100 - - -
ISIN AU000000NAN9
ceo Mr. Michael C. Kavanagh BSc, M.B.A.
Website https://www.nanosonics.com.au
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.